NCT06207123
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06207123
Title A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Chicago
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Chicago Medicine Comprehensive Cancer Center RECRUITING Chicago Illinois 60615 United States Details
University of Rochester Medical Center, Wilmot Cancer Center RECRUITING Rochester New York 14642 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field